06/18/2026
As CCRM marks 15 years of advancing cell and gene therapy, we know that impact doesn’t stop at national borders.
CCRM Australia and CCRM Nordic are key partners in a globally evolving model, originally established in Canada, which brings together industry, academia and government to accelerate the development and commercialization of advanced therapies.
Why does this matter for Canada?
Because building a globally connected ecosystem is essential in a field where science, talent and capital are international. By establishing a presence in regions with strong research excellence and complementary capabilities, we can facilitate the bundling of intellectual property, share expertise and infrastructure, and leverage funding across the major markets. CCRM is helping to attract partners and opportunities to Canada, and we can create synergies in the partner countries.
CCRM Australia has helped strengthen ties across the Asia-Pacific region, supporting clinical translation and ecosystem development in a fast-growing market. Meanwhile, CCRM Nordic taps into one of Europe’s most advanced life sciences clusters, known for its strengths in translational research, data infrastructure and collaborative drug development systems.
As we look ahead, CCRM’s global footprint is not just about reach; it’s about influence and what we can achieve. By linking Canada to key innovation hubs around the world, we’re helping ensure that breakthroughs developed anywhere in the network can benefit patients everywhere.
